IHAM
MRNA icon

Integral Health Asset Management’s Moderna MRNA Stock Holding History

Integral Health Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50,000
Closed -$3.54M – 80
2020
Q3 		$3.54M Hold
50,000
– – 1.08% 33
2020
Q2 		$3.21M Buy
+50,000
New +$2.74M 0.96% 42

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Integral Health Asset Management's MRNA Position: Q2 2023 in Review

Integral Health Asset Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 35,000 shares — an estimated $5.38M sold.

Integral Health Asset Management first reported a position in MRNA in Q2 2022 and held it in 3 quarters. The position peaked at $18M in Q4 2022. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Integral Health Asset Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Integral Health Asset Management sold 35,000 Moderna shares in Q2 2023, an estimated $5.38M.
  • Integral Health Asset Management first reported a position in Moderna in Q2 2022 and held it in 3 quarters.
  • Integral Health Asset Management's Moderna position peaked at $18M in Q4 2022.
  • 966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Integral Health Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.